Back
Cava Group Vs. Denali Therapeutics Industry Stock Comparison
Buy
84
CAVA
Cava Group
Last Price:
125.40
Seasonality Move:
13.04%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.73
Seasonality Move:
17.79%
Buy
84
Cava Group (CAVA)
is a Buy
Is Cava Group a Buy, Sell or Hold?
- The current Cava Group [CAVA] share price is $124.30. The Score for CAVA is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CAVA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CAVA Stock Price Chart
What is Cava Group's stock price today?
-
The Cava Group share price today is $124.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAVA is experiencing slight selling pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
CAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.04 | Buy |
Relative Strength Index (14 RSI): | 67.44 | Buy |
Chaikin Money Flow: | -77164 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.88 - 123.46) | Buy |
Bollinger Bands (100): | (76.48 - 106.68) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.79 | Buy |
Relative Strength Index (14 RSI): | 78.12 | Buy |
Chaikin Money Flow: | -939708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.39 - 28.19) | Buy |
Bollinger Bands (100): | (19.07 - 25.27) | Buy |
CAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.33 | Buy |
20-day SMA: | 117.58 | Buy |
50-day SMA: | 98.58 | Buy |
200-day SMA: | 72.07 | Buy |
8-day EMA: | 121.76 | Buy |
20-day EMA: | 115.82 | Buy |
50-day EMA: | 104.24 | Buy |
200-day EMA: | 77.45 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.69 | Buy |
20-day SMA: | 26.4 | Buy |
50-day SMA: | 24.37 | Buy |
200-day SMA: | 20.59 | Buy |
8-day EMA: | 29.03 | Buy |
20-day EMA: | 26.97 | Buy |
50-day EMA: | 24.8 | Buy |
200-day EMA: | 22.21 | Buy |
Cava Group Earnings Growth & CAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.03 per share, an increase this year of $0.31 per share, and an increase next year of $0.09 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Cava Group Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |